Achieve Life Sciences (ACHV) Competitors $3.14 -0.12 (-3.68%) Closing price 04:00 PM EasternExtended Trading$3.06 -0.08 (-2.68%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACHV vs. RIGL, EBS, XOMA, LXRX, VNDA, CDXS, SGMO, IRWD, DOMH, and AGENShould you be buying Achieve Life Sciences stock or one of its competitors? The main competitors of Achieve Life Sciences include Rigel Pharmaceuticals (RIGL), Emergent BioSolutions (EBS), XOMA (XOMA), Lexicon Pharmaceuticals (LXRX), Vanda Pharmaceuticals (VNDA), Codexis (CDXS), Sangamo Therapeutics (SGMO), Ironwood Pharmaceuticals (IRWD), Dominari (DOMH), and Agenus (AGEN). These companies are all part of the "biotechnology" industry. Achieve Life Sciences vs. Rigel Pharmaceuticals Emergent BioSolutions XOMA Lexicon Pharmaceuticals Vanda Pharmaceuticals Codexis Sangamo Therapeutics Ironwood Pharmaceuticals Dominari Agenus Rigel Pharmaceuticals (NASDAQ:RIGL) and Achieve Life Sciences (NASDAQ:ACHV) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment. Which has more risk & volatility, RIGL or ACHV? Rigel Pharmaceuticals has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500. Comparatively, Achieve Life Sciences has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Does the media refer more to RIGL or ACHV? In the previous week, Achieve Life Sciences had 5 more articles in the media than Rigel Pharmaceuticals. MarketBeat recorded 10 mentions for Achieve Life Sciences and 5 mentions for Rigel Pharmaceuticals. Rigel Pharmaceuticals' average media sentiment score of 1.63 beat Achieve Life Sciences' score of 0.65 indicating that Rigel Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rigel Pharmaceuticals 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Achieve Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of RIGL or ACHV? 66.2% of Rigel Pharmaceuticals shares are held by institutional investors. Comparatively, 33.5% of Achieve Life Sciences shares are held by institutional investors. 9.5% of Rigel Pharmaceuticals shares are held by company insiders. Comparatively, 2.0% of Achieve Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is RIGL or ACHV more profitable? Rigel Pharmaceuticals has a net margin of 2.46% compared to Achieve Life Sciences' net margin of 0.00%. Rigel Pharmaceuticals' return on equity of -14.80% beat Achieve Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Rigel Pharmaceuticals2.46% -14.80% 3.03% Achieve Life Sciences N/A -108.30%-65.20% Does the MarketBeat Community prefer RIGL or ACHV? Rigel Pharmaceuticals received 133 more outperform votes than Achieve Life Sciences when rated by MarketBeat users. However, 70.46% of users gave Achieve Life Sciences an outperform vote while only 68.88% of users gave Rigel Pharmaceuticals an outperform vote. CompanyUnderperformOutperformRigel PharmaceuticalsOutperform Votes46768.88% Underperform Votes21131.12% Achieve Life SciencesOutperform Votes33470.46% Underperform Votes14029.54% Do analysts prefer RIGL or ACHV? Rigel Pharmaceuticals currently has a consensus target price of $36.40, suggesting a potential upside of 73.83%. Achieve Life Sciences has a consensus target price of $14.33, suggesting a potential upside of 356.48%. Given Achieve Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Achieve Life Sciences is more favorable than Rigel Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rigel Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40Achieve Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Which has better earnings & valuation, RIGL or ACHV? Rigel Pharmaceuticals has higher revenue and earnings than Achieve Life Sciences. Achieve Life Sciences is trading at a lower price-to-earnings ratio than Rigel Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRigel Pharmaceuticals$203.08M1.84-$25.09M$2.0710.12Achieve Life SciencesN/AN/A-$29.82M-$1.34-2.34 SummaryRigel Pharmaceuticals beats Achieve Life Sciences on 11 of the 17 factors compared between the two stocks. Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACHV vs. The Competition Export to ExcelMetricAchieve Life SciencesDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$108.91M$2.61B$5.35B$8.38BDividend YieldN/A0.73%5.22%4.10%P/E Ratio-2.787.4326.8419.71Price / SalesN/A35.86391.39116.98Price / CashN/A15.7538.2534.62Price / Book-44.865.546.794.50Net Income-$29.82M-$65.73M$3.23B$248.18M7 Day Performance26.61%2.88%4.07%1.14%1 Month Performance39.56%5.46%12.52%15.20%1 Year Performance-39.03%-16.07%16.83%6.56% Achieve Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACHVAchieve Life Sciences1.885 of 5 stars$3.14-3.7%$14.33+356.5%-35.6%$108.91MN/A-2.7820RIGLRigel Pharmaceuticals2.9818 of 5 stars$18.61-0.9%$36.40+95.6%+110.7%$332.51M$179.28M132.94160Positive NewsEBSEmergent BioSolutions4.4145 of 5 stars$5.85+3.6%$14.33+144.9%+19.7%$318.03M$1.01B-1.432,420Analyst RevisionXOMAXOMA4.0956 of 5 stars$24.79+2.5%$69.50+180.4%+6.3%$296.32M$10.22M-7.1210News CoverageInsider TradeAnalyst RevisionGap UpLXRXLexicon Pharmaceuticals3.2041 of 5 stars$0.67-3.9%$3.67+444.1%-67.8%$243.61M$31.08M-0.90140News CoverageVNDAVanda Pharmaceuticals4.3744 of 5 stars$4.03+2.0%$16.50+309.4%-15.7%$237.50M$198.77M-12.59290CDXSCodexis3.3149 of 5 stars$2.64+7.3%$8.00+203.0%-27.9%$218.71M$59.35M-3.03250Positive NewsEarnings ReportAnalyst RevisionGap UpSGMOSangamo Therapeutics2.0643 of 5 stars$0.75+7.1%$5.17+588.9%-18.8%$171.90M$57.80M-1.00480Analyst RevisionIRWDIronwood Pharmaceuticals4.5318 of 5 stars$0.73+3.5%$4.78+551.9%-89.8%$118.74M$351.41M-24.46220Positive NewsDOMHDominari0.8614 of 5 stars$5.87-2.0%N/A+146.9%$85.96M$18.15M-1.524AGENAgenus3.9729 of 5 stars$3.50+20.3%$8.75+150.0%-64.1%$74.10M$103.46M-0.31440Analyst RevisionGap DownHigh Trading Volume Related Companies and Tools Related Companies RIGL Alternatives EBS Alternatives XOMA Alternatives LXRX Alternatives VNDA Alternatives CDXS Alternatives SGMO Alternatives IRWD Alternatives DOMH Alternatives AGEN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACHV) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
